Want to join the conversation?
$WBA's earnings for 1Q16 increased by about $250MM from last year. The increase was primarily attributable to the full consolidation of Alliance Boots operations, higher sales and lower selling, general and administrative expenses as percentage of sales in Retail Pharmacy USA division, and a lower effective income tax rate.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.